PharmaShots Weekly Snapshots (April 19 - 23, 2021)
BMS' Opdivo + Yervoy and Onureg Receive EC's CHMP Positive Opinion for MPM and AML
Published: Apr 23, 2021 | Tags: BMS, Opdivo, Yervoy, Onureg, Receive, EC, CHMP, Positive Opinion, MPM, AML
Gilead Reports NDA Submission of Filgotinib to PMDA for Ulcerative Colitis in Japan
Published: Apr 23, 2021 | Tags: Gilead, Reports, NDA, Submission, Filgotinib, PMDA, Ulcerative Colitis, Japan
Published: Apr 23, 2021 | Tags: AbbVie, Humira (adalimumab), Receives, Health Canada, Approval, Pediatric, Patients, Active, Ulcerative Colitis
GSK's Jemperli (dostarlimab-gxly) Receives the US FDA's Approval for dMMR Endometrial Cancer
Published: Apr 23, 2021 | Tags: GSK, Jemperli (dostarlimab-gxly), Receives, US, FDA, Approval, dMMR, Endometrial Cancer
Published: Apr 23, 2021 | Tags: Roche, Receives, US, FDA, Approval, First, CDx, Identify, Endometrial Cancer, Patients, Eligible, Immunotherapy
Published: Apr 23, 2021 | Tags: Vertex, Signs, License Agreement, Obsidian Therapeutics, Discover, Regulated, Gene Editing, Therapies
Claritas Collaborates with CMAX to Initiate P-I Study of R-107 for Pulmonary Arterial Hypertension
Published: Apr 22, 2021 | Tags: Claritas, Collaborates, CMAX, Initiate, P-I Study, R-107, Pulmonary Arterial Hypertension
Johnson & Johnson Publishes Results of COVID-19 Single Shot Vaccine in NEJM
Published: Apr 22, 2021 | Tags: Johnson & Johnson, Publishes, Results, COVID-19, Single Shot,, Vaccine, NEJM
Published: Apr 22, 2021 | Tags: AgeneBio, Reports, Completion, Patient Enrollment, P-IIB HOPE4MCI Trial, AGB101, Treat, Amnestic Mild Cognitive Impairment, Alzheimer Disease
Published: Apr 22, 2021 | Tags: TG Therapeutics, Initiates, Patient Enrolment, P-III ULTRA-V Trial, Triple Combination Regimen, Treat, R/R Chronic Lymphocytic Leukemia
Novo Nordisk to Initiate P-IIIa Study for Oral Semaglutide to Treat Obesity
Published: Apr 22, 2021 | Tags: Novo Nordisk, Initiate, P-IIIa Study, Oral Semaglutide, Treat, Obesity
Published: Apr 22, 2021 | Tags: Medtronic, Receives, US, FDA, Approval, Pipeline, Flex Embolization Device, Shield Technology
Published: Apr 21, 2021 | Tags: LEXEO Therapeutics, Receives, US, FDA, Fast Track Designation, LX1001, Treat, APOE4, Associated, Alzheimer Disease
Published: Apr 21, 2021 | Tags: GW Pharmaceuticals, Epidyolex (cannabidiol), Receives, EC, Approval, Treatment, Seizures, Associated, Tuberous Sclerosis Complex
Janssen Collaborates with PhysIQ for Wearable Biosensors and Digital Biomarkers Initiatives
Published: Apr 21, 2021 | Tags: Janssen, Collaborates, PhysIQ, Wearable Biosensors, Digital Biomarkers Initiatives
SparingVision Acquires GAMUT Therapeutics to Expands its Novel Ocular Disease Pipeline
Published: Apr 21, 2021 | Tags: SparingVision, Acquires, GAMUT Therapeutics, Expands, Novel, Ocular Disease Pipeline
Published: Apr 21, 2021 | Tags: Jazz, Presents, Results, Xywav (Oral Solution), P-III Withdrawal Study, Adult Patients, Idiopathic Hypersomnia
Published: Apr 21, 2021 | Tags: Vertex, Amend, Collaboration, CRISPR Therapeutics, Development, Commercialization, CTX001, SCD, Beta Thalassemia
Lilly and Incyte Report Results of Baricitinib in P-III BRAVE-AA1 Study for Severe Alopecia Areata
Published: Apr 20, 2021 | Tags: Lilly and Incyte, Report, Results, Baricitinib, P-III BRAVE-AA1 Study, Severe Alopecia Areata
Published: Apr 20, 2021 | Tags: Janssen, Darzalex (daratumumab, SC), Combination Regimen, Receives, Health Canada, Approval, Patients, Newly Diagnosed, Light Chain Amyloidosis
Published: Apr 20, 2021 | Tags: Biogen, Eisai, Report, Results, Lecanemab (BAN2401), P-IIb Study 201, Patients, Early Alzheimer Disease
Published: Apr 20, 2021 | Tags: Alnylam, Presents, Results, Vutrisiran, P-III HELIOS-A Study, Patients, hATTR Amyloidosis, Polyneuropathy
Published: Apr 20, 2021 | Tags: Astellas, Seagen, Report, US, FDA, Acceptance, Two, sBLA, Padcev (enfortumab vedotin), Locally, Advanced, Metastatic, Urothelial Cancer
Published: Apr 20, 2021 | Tags: Incyte, MorphoSys, Report, First, Patient Dosing, P-III inMIND Study, Relapsed, Refractory, Follicular, Marginal Zone Lymphoma
Published: Apr 19, 2021 | Tags: Novartis, Reports, Results, Kesimpta (ofatumumab), P- III ASCLEPIOS Trials, Newly Diagnosed, Patients, RMS
Published: Apr 19, 2021 | Tags: Janssen, Presents, Results, Nipocalimab (M281), P-II Vivacity-MG Study, Adults, Generalized Myasthenia Gravis
Evotec Signs a License Agreement with Kazia Therapeutics for Clinical Development of EVT801
Published: Apr 19, 2021 | Tags: Evotec, Signs, License Agreement, Kazia Therapeutics, Clinical Development
Published: Apr 19, 2021 | Tags: Sanofi, Sarclisa (isatuximab), Receives, EC, Approval, Adults, Relapsed, Refractory, Multiple Myeloma
Published: Apr 19, 2021 | Tags: Lilly and Incyte, Report, Results, Baricitinib, P-III COV-BARRIER Study, Hospitalized Patients, COVID-19
Published: Apr 19, 2021 | Tags: Zogenix, Presents, Results, Fintepla (fenfluramine) Study, Highlighting, Impact, Treatment, Dravet Syndrome Patients, Caregivers, Families
Related Post: PharmaShots Weekly Snapshots (Apr 12 - 16, 2021)
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com